4//SEC Filing
Olinger Margaret 4
Accession 0000950170-23-033003
CIK 0001658551other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 4:20 PM ET
Size
6.7 KB
Accession
0000950170-23-033003
Insider Transaction Report
Form 4
Olinger Margaret
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-12$0.37/sh+20,000$7,400→ 251,108 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-07-12−20,000→ 69,577 totalExercise: $0.37Exp: 2029-05-13→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]As of the date of this filing, 67,156 shares subject to the option are vested and exercisable. 2,421 shares subject to such option vest and become exercisable in substantially equal monthly installments until August 13, 2023.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001898725
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 4:20 PM ET
- Size
- 6.7 KB